Unexpectedly, most PBC patients had decreased γ-GT and Alk-p levels, which is a marker of UDCA response (21), after 1 year of UDCA treatment, regardless of baseline cirrhosis and UDCA response. Here, ALK is linked to primary biliary cholangitis.